118 HR 4849 IH: Hemp Access and Consumer Safety Act U.S. House of Representatives 2023-07-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS1st SessionH. R. 4849IN THE HOUSE OF REPRESENTATIVESJuly 25, 2023Mr. Blumenauer introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo allow for hemp-derived cannabidiol and hemp-derived cannabidiol containing substances in dietary supplements and food.

1.

Short title

This Act may be cited as the Hemp Access and Consumer Safety Act.

2.

Regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances

(a)

Inclusion in definition of dietary supplement

Section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(ff)(3)(B)) is amended in each of clauses (i) and (ii) by inserting (other than hemp, hemp-derived cannabidiol, or a substance containing any other ingredient derived from hemp) after an article.(b)

Definition

Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321) is amended by adding at the end the following:(tt)The term hemp has the meaning given such term in section 297A(1) of the Agricultural Marketing Act of 1946..(c)

Prohibited act

Section 301(ll) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331(ll)) is amended, in the matter preceding subparagraph (1), by inserting (other than hemp, hemp-derived cannabidiol, or a substance containing any other ingredient derived from hemp) after made public.(d)

Labeling

Consistent with the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), the Secretary of Health and Human Services may—(1)establish labeling and packaging requirements for dietary supplements and food that contain hemp, hemp-derived cannabidiol, or a substance containing any other ingredient derived from hemp; and(2)take additional enforcement actions with respect to products labeled as dietary supplements but not meeting the definition of such term in section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(ff)(3)(B)), as amended by subsection (a).